(0.13%) 5 161.25 points
(0.12%) 38 878 points
(0.07%) 18 013 points
(0.88%) $78.80
(0.19%) $2.15
(0.95%) $2 330.50
(2.50%) $27.36
(0.28%) $968.05
(0.05%) $0.929
(-0.19%) $10.85
(-0.16%) $0.796
(0.09%) $91.54
0.99% KRW 30 600
Live Chart Being Loaded With Signals
Peptron, Inc. engages in the development of peptide-based medicines to treat chronic diseases. The company's technologies include long acting; and SmartDepot, an ultrasonic spray drying technology for the preparation of sustained release injectable microsphere formulation of drug...
Stats | |
---|---|
Volumen de hoy | 666 430 |
Volumen promedio | 673 257 |
Capitalización de mercado | 628.92B |
EPS | KRW0 ( 2024-03-15 ) |
Próxima fecha de ganancias | ( KRW0 ) 2024-05-12 |
Last Dividend | KRW0 ( N/A ) |
Next Dividend | KRW0 ( N/A ) |
P/E | 0 |
ATR14 | KRW121.82 (0.40%) |
Volumen Correlación
Peptron, Inc. Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Peptron, Inc. Correlación - Moneda/Commodity
Peptron, Inc. Finanzas
Annual | 2023 |
Ingresos: | KRW3.34B |
Beneficio Bruto: | KRW-1.75B (-52.48 %) |
EPS: | KRW-773.61 |
FY | 2023 |
Ingresos: | KRW3.34B |
Beneficio Bruto: | KRW-1.75B (-52.48 %) |
EPS: | KRW-773.61 |
FY | 2022 |
Ingresos: | KRW5.81B |
Beneficio Bruto: | KRW-1.47B (-25.25 %) |
EPS: | KRW-730.25 |
Financial Reports:
No articles found.
Peptron, Inc.
Peptron, Inc. engages in the development of peptide-based medicines to treat chronic diseases. The company's technologies include long acting; and SmartDepot, an ultrasonic spray drying technology for the preparation of sustained release injectable microsphere formulation of drug. Its research and development products include Luphere Depot for prostate cancer, endometriosis, uterine fibroids, and puberty; SR-Octreotide (PT201) for the treatment of acromegaly; SR-Exenatide (PT302) to treat type 2 diabetes; and SR-Exenatide (PT320) for Parkinson's and Alzheimer's disease. Peptron, Inc. was founded in 1997 and is headquartered in Daejeon, South Korea.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico